Calidi Biotherapeutics (CLDI) Capital Expenditures (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Capital Expenditures of $29000.0 for Q4 2025, up 480.0% year-over-year from $5000.0 in Q4 2024, and up 7.41% quarter-over-quarter from $27000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Capital Expenditures (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Capital Expenditures history runs 4 years deep, the most recent figure standing at $29000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 480.0% year-over-year to $29000.0; the TTM figure through Dec 2025 stood at $120000.0 (up 650.0% YoY), while the FY2025 annual figure was $120000.0, up 650.0% from the prior year.
- Capital Expenditures for Q4 2025 stood at $29000.0, up from $27000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $489000.0 in Q3 2023, with the low at -$223000.0 in Q2 2023.
- The 4-year median for Capital Expenditures is $28000.0 (2025), against an average of $73500.0.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures sank 98.77% in 2024, then soared 480.0% in 2025.
- Calidi Biotherapeutics' Capital Expenditures stood at $161000.0 in 2022, then plunged by 56.52% to $70000.0 in 2023, then sank by 92.86% to $5000.0 in 2024, then jumped by 480.0% to $29000.0 in 2025.
- Business Quant data shows CLDI's Capital Expenditures at $29000.0 in Q4 2025, $27000.0 in Q3 2025, and $57000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 251.02 Mn |
| 10 | Calidi Biotherapeutics | 1.90 Mn | -2.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Jun 30, 2023 | -223,000.00 |
| Jun 30, 2023 | -223,000.00 |